Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification ; volume:11 ; number:6 ; day:21 ; month:12 ; year:2009 ; pages:1-15 ; date:12.2009
Breast cancer research ; 11, Heft 6 (21.12.2009), 1-15, 12.2009
- Urheber
-
Powe, Desmond G.
- Beteiligte Personen und Organisationen
-
Akhtar, Gulfareen
Habashy, Hany Onsy
Abdel-Fatah, Tarek
Rakha, Emad A.
Green, Andrew R.
Ellis, Ian O.
SpringerLink (Online service)
- DOI
-
10.1186/bcr2461
- URN
-
urn:nbn:de:1111-201603245975
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Powe, Desmond G.
- Akhtar, Gulfareen
- Habashy, Hany Onsy
- Abdel-Fatah, Tarek
- Rakha, Emad A.
- Green, Andrew R.
- Ellis, Ian O.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
Is HER2 amplification predictable by digital immunohistochemistry?
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
RAS/RAF mutations and microsatellite instability status in primary colorectal cancers according to HER2 amplification
HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma
HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis
Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas
HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients
Amplification of HER2 is a marker for global genomic instability
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
Is HER2 amplification predictable by digital immunohistochemistry?
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
RAS/RAF mutations and microsatellite instability status in primary colorectal cancers according to HER2 amplification
HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma
HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis
Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas
HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients
Amplification of HER2 is a marker for global genomic instability
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
Is HER2 amplification predictable by digital immunohistochemistry?
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
RAS/RAF mutations and microsatellite instability status in primary colorectal cancers according to HER2 amplification
HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma
HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis
Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissues
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers
Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas
HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients